Recent Story Posts
Scientific Innovation
A Look at Overall Survival Data in Cancer Clinical Trials
People and Culture
Supporting the LGBTQ+ Community in Oakland: Love is the Answer
Scientific Innovation
Bilal Piperdi on How Gilead is Striving to Create New Possibilities for People with Lung Cancer
Recent Press Releases
-
June 06, 2023
Kite’s Tecartus® CAR T-cell Therapy Demonstrates 78% Complete Response Rate and 90% Overall Response Rate in Largest Real-World Evidence Analysis for Relapsed/Refractory Mantle Cell Lymphoma -
June 05, 2023
Trodelvy® Continues to Show Durable Overall Survival Advantage in Pre-Treated HR+/HER2- Metastatic Breast Cancer
For more information, contact us.
Phone:
1-800-GILEAD-5 (1-800-445-3235)
1-800-GILEAD-5 (1-800-445-3235)